Past Quarters Report of BioPharmX Corporation (NYSEMKT:BPMX)


BioPharmX Corporation (NYSEMKT:BPMX) moved down -5.06% and closed its last trading session at $0.52. This Medical Sector stock currently has the Market Capitalization of 35.6 Million. The Average Volume for the stock is measured as 975.12 Million. The Stock has a 52-Week High of $1.5 and 52-Week Low of $0.19 following the dates, it touched its 52-Week High on Mar 28, 2016 and 52-Week Low on Nov 14, 2016. Currently, the Return on Assets value for the trailing twelve months is -566.1% with the Return on Equity and Return on Investment of 0% and 0% respectively. This firm currently has YTD (year to date) performance of 40.37 Percent which is awesome. The Short Ratio for the stock is 2.11.

BioPharmX Corporation (NYSEMKT:BPMX) Price to Earnings (P/E) ratio is 0. EPS or Earning per Share stands at $-0.66. The TTM operating margin is 0 percent.

BioPharmX Corporation (NYSEMKT:BPMX) reports its Earnings on Thu 23 Mar (In 4 Days). The estimated EPS for the current quarter is said to be $-0.09. Following Earnings result, share price were DOWN 4 times out of last 5 Qtrs. The stock has added about 32.5% since it reported its last earnings. The Closing price of BioPharmX Corporation (NYSEMKT:BPMX) at Last Earnings was $0.4 as compared to the previous closing price of $0.55. The Predicted Move on the 7th day after BioPharmX Corporation (NYSEMKT:BPMX) will release its earnings at about 17%.

By Looking at Earnings History, Out of 12 Quarters when the Earnings were reported, BioPharmX Corporation (NYSEMKT:BPMX) beats earnings by 33%, The Stock Missed Earnings  3  times and has met earnings  0 times.

Earnings History:

We will discuss the past Quarters Earnings below:

BioPharmX Corporation (NYSEMKT:BPMX) reported its previous quarter on 12/13/2016 where it reported the Actual Earnings of $-0.13. The Closing price before the company posted its earnings was $0.4. The Stock surged on the very next day of earnings and maintained its stock price at $0.52 by showing a % change of 30 percent from its previous closing price. The Next Day Volume after Earnings was reported as 8.76 Million. On the 7th day After Earnings Report, the stock hit its share price as $0.37 by showing -7.5% decrease from the Stock price Before Earnings were reported.

On 09/12/2016, the stock reported the EPS of $-0.18 where Analysts were projecting the EPS to be $-0.17 showing a difference of $-0.01. Thus Surprise Factor was there with -5.9 percent. Before Earnings Announcement on 09/12/2016, the firm had its stock price of $0.73. And immediately on the next day after earnings announcement, the stock declined -8.22% and closed its trading session at $0.67. On 7th Day after earnings release, BioPharmX Corporation (NYSEMKT:BPMX) dropped to -4.11% from $0.73 to $0.7.

Company Profile:

BioPharmX Corporation, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women’s health and dermatology markets. The company offers prescription and over-the-counter (OTC) products in oral, topical, and injectable forms. It provides VI2OLET iodine, an OTC molecular iodine dietary supplement that addresses cyclic breast discomfort and for the alleviation of symptoms of fibrocystic breast condition (FBC). The company’s clinical-stage product candidates include BPX03, a molecular iodine tablet for the treatment of benign breast pain associated with FBC and cyclic mastalgia; and BPX01, a topical antibiotic for the treatment of acne. It serves pharmaceutical companies; physician’s practices, including obstetricians and gynecologists, dermatologists, and general practitioners; and retail customers through retail sales channels and/or pharmacy outlets. The company has collaboration and licensing agreement with Iogen LLC for the development of molecular iodine products; and collaboration and supply agreement with NuTech Medical, Inc. to develop products in the field of dermatology. BioPharmX Corporation is headquartered in Menlo Park, California.